article thumbnail

Pharmacogenomics: Creating a Better Healthcare System

MedCity News

While current government and commercial efforts to negotiate competitive drug prices are important, this focus represents a minor—and misplaced—implementation of medication management. It’s time that policymakers, insurers and healthcare providers make pharmacogenomic testing a fundamental standard of care delivery.

article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

Bringing an end to a 13-year deliberation on a whistleblower lawsuit, Biogen recently agreed to pay a $900 million settlement , amidst increased government alertness on pharmaceutical fraud. However, new MS drugs like Novartis ’ Gilenya, were going to soon enter the market and increase competition within the MS therapeutic landscape.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets

PM360

This can be especially important in the current global economic climate, where competition for market share is fierce, and access to new customers is critical for growth. This includes ensuring access and affordability of their products, which can positively impact their environmental social governance (ESG) score and reputation.

article thumbnail

How A Pharma Sales Rep Can Contribute to Society

Contrarian Sales Techniques

While they may not be directly involved in patient care, they play an important role in promoting and educating healthcare providers about the latest treatments and technologies. Another way that pharma sales reps can contribute to society is by fostering partnerships between healthcare providers and pharmaceutical companies.

article thumbnail

Current B2B Marketing Trends in the Healthcare Industry

Scott’s Directories

One of the most competitive industries in the United States is healthcare. government reveal that in 2019, spending on healthcare increased to about $3.8 But despite the success recorded in the healthcare industry, it’s often tough for many B2B healthcare marketers to get into. Statistics from the U.S.

article thumbnail

What health plans should know about healthcare price transparency

Clarify Health

No surprise billing: A breakdown of the key requirements and deadlines in the No Surprises Act The No Surprises Act aims to protect patients from receiving “surprise” (or unexpected) medical bills from a healthcare provider or facility after inadvertently receiving care from an out-of-network provider.

article thumbnail

The price is right (or is it?): decoding price transparency data

Clarify Health

One driver of rising healthcare costs is pricing, particularly the pricing of hospital services, which have been notoriously difficult to see in advance of treatment, and even more difficult to compare across providers and networks. You can learn more about Clarify’s presence at HIMSS23 here: [link].